“Investing is simple. It’s the financial industry that works hard to make it complex!”
― Robert Rolih
Good morning
Equities are up in premarket as earnings continue to filter in from some of the biggest names in their respective sectors. Google earnings were strong and will likely benefit the tech sector. Bitcoin is making a move over 8k so the blockchain crypto plays could get some action today.
Not seeing any news but broke out yesterday potential red to green low floater play
AudioCodes Reports Second Quarter 2018 Results
PR Newswire PR Newswire•July 23, 2018
Declares annual dividend of 20 Cents per Share
Second Quarter Highlights
Quarterly revenues increased by 12.3% year-over-year to $43.5 million;
Quarterly service revenues increased by 14.2% year-over-year to $13.5 million;
Revenues related to UC-SIP business increased more than 30% compared to the second quarter of 2017;
Quarterly GAAP gross margin was 62.3%; quarterly Non-GAAP gross margin was 62.8%;
Quarterly GAAP operating margin was 7.6%; quarterly Non-GAAP operating margin was 10.2%;
Quarterly cash flow from operating activities was $2.2 million;
Quarterly GAAP net income was $2.4 million, or $0.08 per diluted share; quarterly Non-GAAP net income was $4.1 million, or $0.14 per diluted share;
AudioCodes repurchased 452,000 of its ordinary shares during the quarter at an aggregate cost of $3.3 million.
Flirting with an 8 roll 9 is a big spot on the weekly more of a swing play small float
Potential red to green follow through but tends to pop and flop do not chase
Potential follow through looking for a 6 test and roll day trade or potential swing on pull to 5 area as support
VSI The Vitamin Shoppe Appoints Sharon Leite As CEO, Effective August 27 Up several days in a row could get an 8 test and roll
DOMO Cowen & Co. Initiates Coverage On Domo with Outperform Rating, Announces $27 Price Target Potential bounce area looking for a 20 test and roll
OSTK Overstock.com Reports Launch Of Newly-Remodeled Property Mgmt. Site, Houserie also a crypto play looking for a 50 ma bounce
PLX
Protalix BioTherapeutics Expands Partnership with Chiesi Farmaceutici to Include Exclusive U.S. Rights for the Development and Commercialization of PRX-102; Co. To Receive $25M Up Front, $20M In Development Costs, And $760M In Potential Milestones gapping off this pr breaking out of downward trend channel testing the 200 day in premarket potential follow thorough see if .50 cents holds as support for a bounce
